Subpart D—Provisional health effects guidelines RegSenseToxic Substances Control Act - EPAToxic Subtances Control Act - EPAToxic Substance ControlCFR SubpartCFR RegulationsEnvironmental Protection Agency (EPA)EnvironmentalEnglishFocus AreaUSA
§795.225 Dermal pharmacokinetics of DGBE and DGBA.§795.228 Oral/dermal pharmacokinetics.§795.231 Pharmacokinetics of isopropanal.§795.232 Inhalation and dermal pharmacokinetics of commercial hexane.§795.250 Developmental neurotoxicity screen.['Toxic Substances Control Act - EPA']['Toxic Subtances Control Act - EPA']